NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced the pricing of an underwritten public offering of 4,629,630 shares of its common stock at a price to the public of $27.00 per share.
January 5, 2021
· 4 min read